PURPOSE: To evaluate whether pretreatment combined endorectal magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) findings are predictive of outcome in patients who undergo external beam radiotherapy for prostate cancer. METHODS AND MATERIALS: We retrospectively identified 67 men with biopsy-proven prostate cancer who underwent combined endorectal MRI and MRSI at our institution between January 1998 and October 2003 before whole-pelvis external beam radiotherapy. A single reader recorded tumor presence, stage, and metabolic abnormality at combined MRI and MRSI. Kaplan-Meier survival and Cox univariate and multivariate analyses explored the relationship between clinical and imaging variables and outcome, using biochemical or metastatic failure as endpoints. RESULTS: After a mean follow-up of 44 months (range, 3-96), 6 patients developed both metastatic and biochemical failure, with an additional 13 patients developing biochemical failure alone. Multivariate Cox analysis demonstrated that the only independent predictor of biochemical failure was the volume of malignant metabolism on MRSI (hazard ratio [HR] 1.63, 95% confidence interval [CI] 1.29-2.06; p < 0.0001). The two independent predictors of metastatic failure were MRI tumor size (HR 1.34, 95% CI 1.03-1.73; p = 0.028) and the finding of seminal vesicle invasion on MRI (HR 28.05, 95% CI 3.96-198.67; p = 0.0008). CONCLUSIONS: In multivariate analysis, MRI and MRSI findings before EBRT in patients with prostate cancer are more accurate independent predictors of outcome than clinical variables, and in particular, the findings of seminal vesicle invasion and extensive tumor predict a worse prognosis.
PURPOSE: To evaluate whether pretreatment combined endorectal magnetic resonance imaging (MRI) and magnetic resonance spectroscopic imaging (MRSI) findings are predictive of outcome in patients who undergo external beam radiotherapy for prostate cancer. METHODS AND MATERIALS: We retrospectively identified 67 men with biopsy-proven prostate cancer who underwent combined endorectal MRI and MRSI at our institution between January 1998 and October 2003 before whole-pelvis external beam radiotherapy. A single reader recorded tumor presence, stage, and metabolic abnormality at combined MRI and MRSI. Kaplan-Meier survival and Cox univariate and multivariate analyses explored the relationship between clinical and imaging variables and outcome, using biochemical or metastatic failure as endpoints. RESULTS: After a mean follow-up of 44 months (range, 3-96), 6 patients developed both metastatic and biochemical failure, with an additional 13 patients developing biochemical failure alone. Multivariate Cox analysis demonstrated that the only independent predictor of biochemical failure was the volume of malignant metabolism on MRSI (hazard ratio [HR] 1.63, 95% confidence interval [CI] 1.29-2.06; p < 0.0001). The two independent predictors of metastatic failure were MRI tumor size (HR 1.34, 95% CI 1.03-1.73; p = 0.028) and the finding of seminal vesicle invasion on MRI (HR 28.05, 95% CI 3.96-198.67; p = 0.0008). CONCLUSIONS: In multivariate analysis, MRI and MRSI findings before EBRT in patients with prostate cancer are more accurate independent predictors of outcome than clinical variables, and in particular, the findings of seminal vesicle invasion and extensive tumor predict a worse prognosis.
Authors: J Scheidler; H Hricak; D B Vigneron; K K Yu; D L Sokolov; L R Huang; C J Zaloudek; S J Nelson; P R Carroll; J Kurhanewicz Journal: Radiology Date: 1999-11 Impact factor: 11.105
Authors: A V D'Amico; R Whittington; B Malkowicz; M Schnall; D Schultz; K Cote; J E Tomaszewski; A Wein Journal: J Urol Date: 2000-09 Impact factor: 7.450
Authors: Daniel H Clarke; Stephen J Banks; A Roger Wiederhorn; John W Klousia; Jeanne M Lissy; Michelle Miller; Arnold M Able; Carlos Artiles; William V Hindle; Deborah N Blair; Russell R Houk; Michael J Sheridan Journal: Int J Radiat Oncol Biol Phys Date: 2002-03-15 Impact factor: 7.038
Authors: Fergus V Coakley; John Kurhanewicz; Ying Lu; Kirk D Jones; Mark G Swanson; Silvia D Chang; Peter R Carroll; Hedvig Hricak Journal: Radiology Date: 2002-04 Impact factor: 11.105
Authors: Paul L Nguyen; Richard Whittington; Sophia Koo; Delray Schultz; Kerri B Cote; Marian Loffredo; Clare M Tempany; David S Titelbaum; Mitchell D Schnall; Andrew A Renshaw; John E Tomaszewski; Anthony V D'Amico Journal: Int J Radiat Oncol Biol Phys Date: 2004-06-01 Impact factor: 7.038
Authors: Ofer Yossepowitch; Kanishka Sircar; Peter T Scardino; Makoto Ohori; Michael W Kattan; Thomas M Wheeler; Victor E Reuter Journal: J Urol Date: 2002-11 Impact factor: 7.450
Authors: Anton Ponholzer; Sophina Trubel; Paul Schramek; Florian Wimpissinger; Hans Feichtinger; Christopher Springer; Clemens Wehrberger; Katja Fischereder; Karl Pummer; Thomas Martini; Roman Mayr; Armin Pycha; Stephan Madersbacher Journal: World J Urol Date: 2014-02-08 Impact factor: 4.226
Authors: Valdair F Muglia; Antonio C Westphalen; Zhen J Wang; John Kurhanewicz; Peter R Carroll; Fergus V Coakley Journal: AJR Am J Roentgenol Date: 2011-12 Impact factor: 3.959
Authors: Antonio C Westphalen; Walter J Koff; Fergus V Coakley; Valdair F Muglia; John M Neuhaus; Ralph T Marcus; John Kurhanewicz; Rebecca Smith-Bindman Journal: Radiology Date: 2011-08-24 Impact factor: 11.105